Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
41 studies found for:    " February 27, 2008":" March 28, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 27, 2008":" March 28, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Reactogenicity and Immunogenicity of Vaginal CNgp140
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Biological: HIV glycoprotein CN54gp140 (vaccine);   Biological: Carbopol 974
2 Completed Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Standard continuous antiretroviral therapy;   Drug: CD-4 guided therapy interruption;   Drug: Viral load driven treatment interruption
3 Completed Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Conditions: HIV Infections;   HIV Positive;   Pregnant Women
Intervention:
4 Completed Yoga for the Management of HIV-Metabolic Syndromes
Conditions: HIV Infections;   HIV Metabolic Cardiovascular Syndrome;   HIV Lipodystrophy;   HIV Metabolic Syndromes;   Hypertension
Interventions: Behavioral: Yoga lifestyle intervention;   Other: Standard of care
5 Completed Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss
Conditions: HIV Infections;   Unintended Weight Loss;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
6 Completed
Has Results
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
Conditions: HIV -1 Infection;   HIV Infections
Interventions: Drug: PRO 140 (humanized monoclonal antibody to CCR5);   Drug: Placebo Comparator
7 Completed HIV Prevention With the Mentally Ill
Condition: HIV Infections
Interventions: Behavioral: Skills Building with Motivational Interviewing;   Behavioral: Skills Building
8 Completed Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting
Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting;   HIV Infections
Interventions: Drug: Dronabinol;   Drug: Placebo
9 Completed Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples
Conditions: HIV Infections;   Sexually Transmitted Disease
Interventions: Behavioral: Eban HIV/STD Risk Reduction Intervention;   Behavioral: Eban Health Promotion Intervention
10 Completed HORIZONS HIV Intervention
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: HORIZONS HIV Intervention;   Behavioral: enhanced standard-of-care
11 Completed Effectiveness of an Abstinence-Only HIV/Sexually Transmitted Disease Risk-Reduction Intervention for Young African-American Adolescents
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: Abstinence-only HIV/STD risk-reduction intervention;   Behavioral: Safer-sex-only HIV/STD risk-reduction intervention;   Behavioral: Long comprehensive HIV/STD risk-reduction intervention;   Behavioral: Short comprehensive HIV/STD risk-reduction intervention;   Behavioral: Health promotion control intervention
12 Completed Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania
Condition: HIV Infections
Interventions: Behavioral: Couples VCT;   Behavioral: Individual VCT
13 Active, not recruiting Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Conditions: HIV Infections;   Staphylococcal Infections
Interventions: Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%;   Drug: Placebo
14 Completed An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
Condition: HIV Infections
Intervention: Drug: Emtricitabine
15 Completed Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Conditions: Pregnancy;   HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: CenteringPregnancy Plus (CP+);   Behavioral: Usual care
16 Unknown  Impact of Antiretroviral Therapy on Cardiac Biomarkers
Condition: HIV Infections
Intervention:
17 Completed Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
18 Completed Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)
Condition: HIV Infections
Interventions: Behavioral: Cognitive behavioral coping effectiveness training;   Behavioral: Standard care;   Behavioral: Single group workshop on coping effectiveness training
19 Completed Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
20 Completed Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China
Conditions: HIV Infections;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Physician Ai Shi Zi training;   Drug: Standard care;   Behavioral: Patient risk-reduction counseling

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years